Provider review
Idgie Health review: it promises nothing about your weight, and hides a fee in its terms
Idgie Health's product pages say almost nothing about results. No percentage, no pounds figure, no timeline, no testimonial, no before-and-after. The semaglutide page's whole promise is a tagline: less hunger, steady progress. That's a mechanism and a direction, not a quantity, and there's nothing in it for a trial to contradict. The problem is elsewhere. Its terms describe a membership fee repeatedly, its pricing pages never mention one, and no second number appears anywhere on the site.
Claims almost nothing about results, then describes a membership fee in its terms that none of its pricing pages mentions.
Worth trusting if
- You want a seller that describes an effect rather than promising you a number
- You want the flat-price promise attached to the plan itself, which it is on semaglutide
- You might want to move the prescription to a local pharmacy later
Be skeptical if
- You want every charge named on the page that sells you the plan
- You want to know which pharmacy makes your medication, or whether it is made to order at all
- You are buying tirzepatide and relying on the flat-price promise, which is not stated for that drug
Compounded only
Phase 3 trials
Not named
None found
Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.
Opens www.idgiehealth.com. A link is not a recommendation to take anything.
Provenance
What Idgie Health actually dispenses
Regulatory category is the axis consumers are most reliably misled about, so it comes first. Every product below is sorted by what it legally is, not by what it costs.
Prepared by a state-licensed pharmacy against a prescription for a named patient. Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
- Compounded semaglutide injection — $149 a month; the advertised $114 needs six months paid up front.
- Compounded tirzepatide injection — $229 a month; the advertised $171 needs six months up front.
Evidence
Has the molecule been tested for what it is sold for?
One row per product, graded on how far the published human evidence goes for the MOLECULE inside it, for the use it is sold for — not for the molecule in general, and never a claim about this seller. Nobody trials a compounded preparation; what a trial can tell you is whether the molecule has been tested for the thing it is being advertised to do. A molecule with phase 3 evidence for one outcome has none for another, and that distinction is where peptide marketing lives.
2
Molecules with human evidence
For the use they are sold for, out of 2 products reviewed here. The evidence belongs to the molecule, not to Idgie Health.
2
Registry records cited
Each read live from ClinicalTrials.gov, never from memory. None of them tested this company's product.
The comparison
What they claim, against what the trials show
Each claim below is quoted verbatim from Idgie Health’s own page, with the page it came from. Grading a paraphrase would prove nothing. Every row is the verdict at a glance — tap it to open the quote, the trial registry entries, and the full note behind that verdict.
Compounded semaglutide injectionSemaglutide · Compounded (503A)Claim matches the trials
“Less hunger. Steady progress. 1 Month · Billed monthly · all doses. Licensed provider oversight. Free discreet shipping. Pause or cancel.”
Read on the Idgie Health site, September 2026
Phase 3 trials
What the trials show for Semaglutide
- NCT03548935 STEP 1 — Phase 3, completed, n=1,961. 68 weeks in 1,961 adults, titrated to semaglutide 2.4 mg, mean weight reduction of about 15%. Listed as the molecule's evidence base; Idgie cites no trial anywhere on its site.
"Less hunger. Steady progress" is about as small a claim as a seller can make and still be selling something. It names an effect the molecule genuinely has — appetite suppression is the mechanism, not a side benefit — and attaches no number, no timeline and no rate to it. There is nothing here for STEP 1 to contradict. The one claim worth crediting sits on the plan rather than in the marketing: "all doses" is printed on the monthly tier itself, which is the right place for a flat-price promise, because a promise attached to the thing you buy is harder to quietly drop than one in a banner.1
Compounded tirzepatide injectionTirzepatide · Compounded (503A)Claim matches the trials
“One weekly dose. 1 Month · Billed monthly, flexible. Licensed provider oversight. Free discreet shipping. Pause or cancel.”
Read on the Idgie Health site, September 2026
Phase 3 trials
What the trials show for Tirzepatide
- NCT04184622 SURMOUNT-1 — Phase 3, completed, n=2,539. 72 weeks in 2,539 adults at 5, 10 and 15 mg once weekly. Again the molecule's evidence base rather than a citation Idgie makes.
"One weekly dose" is the entire claim, and it is accurate — tirzepatide is a once-weekly injection. Nothing about weight, rate or outcome appears on the page. Worth noting what is missing rather than wrong: the flat-price wording that sits on the semaglutide plan does not appear on any tirzepatide tier, which are labeled monthly and flexible instead. So the promise that the price holds at every dose is demonstrable for one of Idgie's two drugs and not the other, and the site never addresses the difference.2
Dispensing chain
Who actually fills your prescription
Read the full account
No individual pharmacy is named and no compounding tier is stated anywhere, so nothing tells you whether your medication is made to order under a prescription or dispensed ready-made. What the terms describe instead are two pharmacy networks, in the same document — Idgie's own, under which a differently-formed company called Idgie Health LLC is itself listed as a selectable option, and a second one operated by the telehealth platform it licenses. Nothing explains how those two entities relate. Against that, Idgie does something rare: it tells you plainly that you may move the prescription to a local pharmacy at any time, by phone or email. It also prices the consequence, which is that the fee then stops covering your medication. No clinician is named at any level.
Read on the Idgie Health site, September 2026.
Quality
Third-party testing, and what is published
Describes a testing regime
Nothing published on the pages searched
Certificate of analysis readable
No lot report a buyer can open
Read the full testing account
No certificate of analysis, potency, purity or sterility result appears anywhere — and neither does the marketing that usually stands in for one. There is no patient count, no satisfaction figure, no testimonial and no before-and-after photograph on either product page. The one thing Idgie publishes that a reader should chase is in the opposite direction: its terms describe a recurring membership fee covering care and pharmacy services, and state that filling at a local pharmacy means that fee stops including the medication. No pricing page uses the word, and no second figure appears anywhere on the site, so what that fee is and whether the plan price already is it cannot be answered from what is published.
Read on the Idgie Health site, September 2026.
Licensing
Licensed to dispense, and where
Coverage
Idgie Health publishes no list of states and claims no nationwide coverage, on its product pages, its terms or its shipping policy, checked on September 13, 2026. Its terms route coverage through the independent doctors who write the prescriptions rather than stating a service area.
Read the full licensing claim
The operator is named, twice — Idgie Health is a trading name of Feel Better Health Group, LLC, described in its own terms as a healthcare management company. No street address or state of incorporation appears; the published contacts are an email address and a phone number with an Alaska area code. No clinician is named.
Read on the Idgie Health site, September 2026.
Regulatory
The FDA warning letter
Checked, and none found
Assessment
What holds up, and what does not
- Its product pages carry no weight-loss percentage, no timeline and no before-and-after, so nothing overstates the trials.
- "All doses" is printed on the monthly semaglutide plan itself rather than in a marketing banner.
- There are no testimonials, no patient count and no satisfaction figure to be misled by.
Show 4 more
- It names its operating company twice in its own terms.
- You may move the prescription to a local pharmacy at any time, stated plainly.
- It tells you the consequence of moving it, rather than letting you find out on a bill.
- No FDA warning letter, for the brand or for Feel Better Health Group, LLC.
- Its terms describe a membership fee that appears on no pricing page and has no figure attached anywhere.
- No pharmacy is named, and nothing says whether the medication is made to order or dispensed ready-made.
- Two differently-formed companies share the brand, and nothing explains how they relate.
Show 4 more
- The flat-price wording sits on the semaglutide plan and on none of the tirzepatide ones.
- No trial is cited anywhere, so nothing connects either product to published evidence.
- No clinician is named — only "licensed provider oversight" on each page.
- No street address is published, just an email and a phone number.
Verdict
The bottom line
There is very little here to argue with, because there is very little here. Idgie describes an effect, attaches no number to it, and leaves the trials alone. Before you buy, get one question answered in writing: is the plan price the membership fee its terms keep describing, or is there a second charge? And if you are buying tirzepatide, ask whether the price really holds at every dose, because that promise is printed only on the other drug.
Opens www.idgiehealth.com. A link is not a recommendation to take anything.
The smallest claim in the batch
Idgie Health's semaglutide page, in full, on the question of what the drug does:
"Less hunger. Steady progress."
That's it. We swept both product pages and the terms on 13 September 2026 for a weight-loss percentage, a pounds figure, a timeline, a success rate, a testimonial or a before-and-after. None of them exists.
The tagline is accurate as far as it goes. Appetite suppression is the mechanism 1, and "steady progress" names a direction rather than a quantity. There's nothing in it for a trial to contradict.
Which also means there's nothing in it. Idgie cites no trial, publishes no clinical page, and tells you nothing about what these drugs have been shown to do.
Full analysis — 3 more sectionsThe promise in the right place · The fee that isn't on the price list · Two networks, two companies
The promise in the right place
One thing worth crediting. On the monthly semaglutide plan:
"1 Month · Billed monthly · all doses"
Not in a banner. On the plan itself.
That matters because a flat-price promise is the one most likely to quietly stop being true. An advertised price is usually pegged to a starting dose, and the cost appears when you titrate up. Printing "all doses" on the thing you're buying makes it part of the offer.
The tirzepatide plans don't say it. They're labeled "billed monthly, flexible" instead. So the promise is demonstrable for one of Idgie's two drugs and not the other, and the site never mentions the difference.
The fee that isn't on the price list
From the terms, describing what you're buying:
"…at-home phlebotomy services, medication at the discretion of the Member's provider, and pharmacy services for a recurring monthly payment."
And then:
"If you choose to have your prescription filled at a local pharmacy, your Membership Fee will not include the cost of medication and pharmacy fulfillment."
Neither product page uses the word "membership". No second figure appears anywhere on the site.
So either the plan price is the membership fee, with the medication inside it — which is how the plan reads — or there's a charge nobody has priced. The site doesn't settle it, and that's a question to put to support in writing before ordering.
Two networks, two companies
The same terms describe the Idgie Health Pharmacy Network, under which a company called Idgie Health LLC is itself listed as a pharmacy you can select — a differently-formed entity from Feel Better Health Group, LLC, named as the operator. Separately, a Bask Pharmacy Network.
No individual pharmacy is named in either. No compounding tier is stated, so nothing tells you whether your medication is made to order under your prescription or dispensed ready-made.
Questions
Frequently asked questions
Does Idgie say how much weight I'd lose?
No — there's no percentage, pounds figure or timeline anywhere on its product pages or its terms. The whole outcome claim on the semaglutide page is its tagline, less hunger and steady progress. That's honest as far as it goes, and it means the site gives you nothing to set expectations against.
Is there a membership fee?
This is the question the site won't answer. Idgie's terms describe a recurring membership fee covering care and pharmacy services, and say that filling at a local pharmacy means the fee stops including your medication. Neither product page uses the word and no second number appears anywhere, so ask support in writing before you order.
Does the price hold as my dose goes up?
On the monthly semaglutide plan, yes — "all doses" is printed on the plan itself, which is the best place for that promise. The tirzepatide plans carry no equivalent wording, so we'd confirm it separately for that drug rather than assume it carries over.
Which pharmacy fills an Idgie prescription?
Idgie doesn't say. Its terms describe its own pharmacy network and a second one run by the telehealth platform it licenses, and name no individual pharmacy in either. Nothing says whether your medication is made to order under a prescription or dispensed ready-made.
Can I use my own pharmacy?
Yes, and Idgie tells you the catch. The terms say you may move the prescription to a local pharmacy at any time by phone or email, and that if you do, your fee stops covering the medication and the pharmacy fulfillment. You'd be paying Idgie for care and the pharmacy for the drug.
Glossary
Key terms
Show definitions
- Compounded
- Made to order by a pharmacy for an individual patient rather than manufactured and approved as a finished product. Compounded drugs are not FDA-approved and the FDA has not evaluated their safety, effectiveness or quality.
- Titration
- Starting at a low dose and stepping up over weeks to a target. It's why a flat-price promise matters — the cost of a GLP-1 usually appears on the way up, not at the start.
- STEP 1
- The phase 3 trial of once-weekly semaglutide 2.4 mg for weight loss — 1,961 adults over 68 weeks, published in the New England Journal of Medicine in 2021.
Compare
Others selling what Idgie Health sells
Companies we have also reviewed that dispense at least one of the same compounds, ordered by how much of what they say about their products matches the trials behind them. Nothing here is a recommendation, and none of these links earns us anything.
Method
How we checked this
Non-product facts last checked September 2026. Read the editorial policy for the rules this page is held to.
Read our methodology
Claims read first-party
Every quoted claim was read off Idgie Health's own pages, first-hand, on the date stamped against it — never from a summary, an aggregator, or an earlier version of this review.
Trials read from the registry
Phase, status and enrollment come from ClinicalTrials.gov; identifiers and journals from PubMed's own records. Nothing here is cited from memory.
Absence claims bounded
Where we report that no trial exists, the page says what was searched, where, and when — never an unbounded claim that nobody has tested something.
Letters matched on full name
FDA letters are matched on the complete company name. A substring match would attach one firm's regulatory history to another with a similar name.
Sources
References
Show all 2 sources
- Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — 1,961 adults over 68 weeks, mean weight reduction of about 15%. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT03548935
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — 2,539 adults over 72 weeks at 5, 10 and 15 mg once weekly. New England Journal of Medicine. https://clinicaltrials.gov/study/NCT04184622
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.